Infertility
Conditions
Brief summary
The purpose of this study is to evaluate the safety and efficacy of highly purified (HP) menotrophine to Korean women.
Interventions
None listed
Sponsors
Ferring Pharmaceuticals
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Anovulation in women (WHO group II) * Controlled ovarian hyperstimulation cases for ART
Exclusion criteria
* Hypersensitivity to MENOPUR * Pregnancy, lactation or contraindication to pregnancy * Ovarian cysts not related to polycystic ovarian syndrome * Abnormal uterine bleeding * Tumors in uterus, ovaries and breasts * Ovarian hyperstimulation syndrome * Thromboembolism or history of it * Infertile due to other reason than anovulation * High FSH level indication primary ovarian failure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of follicles per cycle | Up to 6 weeks | An ART cycle: From ovulation (number and size) to when chemical pregnancy test results are recorded |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of adverse events | Up to 6 weeks | An ART cycle: From ovulation (number and size) to when chemical pregnancy test results are recorded |
Countries
South Korea
Outcome results
None listed